Sulfurous Eructation During GLP-1 Agonist Therapy: Mechanistic Rationale for Bismuth Subsalicylate
Abstract
This pre-print presents a narrative evidence synthesis evaluating the mechanistic rationale and clinical implications of using bismuth subsalicylate (BSS) for sulfurous eructation associated with GLP-1 and dual GLP-1/GIP receptor agonists.
Fields of Study & Subjects
Diabetes Treatment and Management
Pharmacology and Obesity Treatment
Gastroesophageal reflux and treatments
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 10 March 2026
- Language
- EN
- Document type
- Preprint